The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
December 26th 2024
From groundbreaking therapies to ethical dilemmas, HCPLive’s top podcasts of 2024 delivered expert insights and human stories across medicine.
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Military Spends $84 Million on Erectile Dysfunction Drugs
February 24th 2015The Department of Defense spent more than $84 million on erectile dysfunction medications in 2014, according to a report in Military Times. Nearly half of that, $41.6 million, was spent on Viagra, with military doctors writing nearly a million prescriptions for that drug alone last year.
Pulmonary Embolism Surgery Safe, Effective
Treating acute pulmonary embolism patients with surgery to remove the clot fell out of favor in the 1950s because of high mortality rates. But safety seems to have improved dramatically-at least at one health care system. In a study published in the Texas Heart Institute Journal Alan Hartman, MD chair of cardiovascular and thoracic surgery at the North Shore-LIJ health system report on a retrospective review of 96 patients at the NY system.
Arrhythmia: Tapping the Power of the Pig
Studying the possible causes of inherited arrythmias is difficult using genetically altered mice or cultured human cells. But in a research breakthrough, doctors at NYU Langone Medical Center in Manhattan have come up with a genetically engineered pig. Since pig hearts function much like those of humans, that has made their work much more effective, says David S. Park, MD, PhD an assistant professor of cardiology at NYU Langone.
Cutting-Edge Heart Model Predicts Changes in the Heart That Can Lead to Atrial Fibrillation
A paper from a pair of physicists may reveal significant new information about the causes of atrial fibrillation and help to make cardiac ablations a more effective treatment for the condition.
Patch Provides New Tool in Heart Condition Diagnosis
There are new tools being developed everyday to help patients and healthcare professionals diagnose a wide variety of conditions. One recent study looked at the compliance levels achieved by a patch that can be used to help check a patient's heart health.
Endovascular Therapy Numbers Tell Important Story
The more endovascular therapy is used in the treatment of stroke patients the more data there will be about its efficacy. Looking at those numbers and determining what they man can be as important as the procedures themselves.
Mr. CLEAN Study Shows Simpler Path for Endovascular Therapy
While other endovascular therapies presented at the International Stroke Conference required more specialized imaging to reach their final results the authors of one study showed that more basic work can be just as effective.
Endovascular Therapy Gets Fresh Look with New Technology
It was not long ago that the merits of endovascular therapy were questioned by some in the healthcare field. A recent push and some new tools have given the debate a stronger argument in favor of the procedures.
SWIFT PRIME Shows Strong Results for Endovascular Therapy
As one of the key presentations at the International Stroke Conference the results of the SWIFT PRIME study showed that when conducted in the right circumstances the procedure can provide great benefits for stroke patients.
Dehydration Signals Worse Stroke Outcome
Dehydrated stroke patients tend to do worse than those who are hydrated, a Johns Hopkins team found. The next question is whether all such ischemic stroke patients should get fluids when they arrive at the hospital, contrary to current recommendations.
Clot-busters Safe in Wake-Up Strokes
Patients who have strokes during their sleep pose a treatment conundrum. Since it is hard to assess when the stroke happened, physicians may not know whether to administer clot-busting tPA. The drug is thought to have a therapeutic window of 3 hours. A Texas study suggests tPA is safe for these patients even if the 3-hr window has closed.